7 Results for "

dna-pk-in-13

" in MedChemExpress (MCE) Product Catalog:
Products (7)

7 Results for "dna-pk-in-13" in MCE Product Catalog:

Cat. No.: HY-163134
CAS No.: 2792146-91-7
Target:  

DNA-PK

Research Areas:  

Cancer

DNA-PK-IN-12 (compound 31t) is an oral active DNA-PK inhibitor with the IC50 of 0.1 nM. DNA-PK-IN-12 inhibits cell growth and Hct116 cell colony formation with the IC50 of 33.28 μM, and shows antitumor activity in vivo .
loading...
    loading...
Cat. No.: HY-153943
CAS No.: 2919315-89-0
Target:  

DNA-PK

Research Areas:  

Cancer

DNA-PK-IN-10 is a DNA-PK inhibitor. DNA-PK-IN-10 can be used for the research of breast cancer and non-small cell lung cancer .
loading...
    loading...
Cat. No.: HY-162692
CAS No.: 2766001-96-9
Target:  

DNA-PK

Research Areas:  

Cancer

DNA-PK-IN-14 (compound 78) is a potent, selective DNA-PK inhibitor with an IC50 value of 7.95 nM. DNA-PK-IN-14 has oral activity and has the potential to be a radiosensitizer for cancer treatment .
loading...
    loading...
Cat. No.: HY-169248
CAS No.: 2663852-17-1
Target:  

DNA-PK

Research Areas:  

Others

DNA-PK-IN-15 (compound 6) is an inhibitor of DNA-PK with an IC50 value of 0.08 nM .
loading...
    loading...
Cat. No.: HY-142943
CAS No.: 2663850-40-4
Target:  

DNA-PK

Research Areas:  

Cancer

DNA-PK-IN-1 is a potent inhibitor of DNA-PK. DNA-dependent protein kinase (DNA-PK) is a DNA-PK enzyme complex composed of Ku70/Ku80 heterodimer and DNA-dependent protein kinase catalytic subunit (DNA-PKcs). DNA-PK-IN-1 has the potential for the research of cancer diseases (extracted from patent WO2021136463A1, compound 1) .
loading...
    loading...
Cat. No.: HY-144036
CAS No.: 2734846-19-4
Target:  

DNA-PK

Research Areas:  

Cancer

DNA-PK-IN-3 is a potent inhibitor of DNA-PK. DNA-PK-IN-3 synergistically enhances the effect of radiotherapy and chemotherapy and effectively inhibits tumor growth. DNA-PK-IN-3 also effectively reduces the damage to normal cells and reducing side effects. DNA-PK-IN-3 has the potential for the research of cancer disease (extracted from patent WO2021213460A1, compound 4) .
loading...
    loading...
Cat. No.: HY-181848
Target:  

DNA-PK Apoptosis

Research Areas:  

Cancer

DNA-PK-IN-16 is an orally active DNA-dependent protein kinase (DNA-PK) inhibitor with an IC50 of 10.2 nM. DNA-PK-IN-16 induces the upregulation of γH2A.X, a biomarker of DNA double-strand breaks. DNA-PK-IN-16 exhibits antiproliferative activity in various cancer cell lines. DNA-PK-IN-16 enhances the infiltration of CD8 + T cells in tumor tissues through synergistic action with anti-PD-L1 monoclonal antibody. DNA-PK-IN-16 is applicable for cancer research .
loading...
    loading...